On Friday, 11 September 2015 five public interest groups (Health GAP, Knowledge Ecology International, Médecins Sans Frontières, Oxfam America and Public Citizen) sent a letter to Ambassador Michael Froman (United States Trade Representative) and Michelle Lee, (Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office) requesting that the Obama administration disclose its position on the LDC request for an extension of their pharmaceutical production transition period under the WTO TRIPS Agreement.
These were comments KEI provided to the Medicines Patent Pool (MPP), for its consultation on expanding the mandate to include drugs to treat the hepatitis C virus.
To: consultation@medicinespatentpool.org.
Date: August 28, 2015
Re: Comments by James Love on behalf of KEI for the consultation regarding the MPP mandate to expand into HCV (and other diseases).
KEI has submitted joint comments with UAEM in this consultation. Here on behalf of KEI I make a few additional points.
IMS Health, the global information and technology services company, known for its statistics on sales of drugs, published a study in May 2015 that estimated the global market for oncology drugs now exceeds $100 billion per year.
This press release was distributed this morning, August 5, 2015, after KEI released the final sections of the TPP Chapter on Intellectual Property. The full text of the chapter is available here: /tpp/11may2015-ip-text.
5 August 2015
CONTACT: Zack Struver
+1 (202) 332-2670
zack.struver@keionline.org
Knowledge Ecology International Leaks Copyright Provisions in Trans-Pacific Partnership
August 4, 2015. Press Release for initial release of patent and enforcement provisions: Knowledge Ecology International Leaks TPP Text on Intellectual Property, (PDF)
After two days of intense negotiations over the future work program of WIPO’s Standing Committee on the Law of Patents (SCP), the committee achieved consensus at around 3:40 PM Geneva time on Friday, 31 July 2015.
The future work of WIPO’s main normative committee dealing with patents now has a pathway on the following work streams: Continue Reading →
On 30 July 2015 at 8:30 PM Geneva time, the Chair (Bucura Ionescu, Romania) of WIPO’s 22nd Standing Committee on the Law of Patents (SCP) distributed the following non-paper related to the proposal by the Group of Latin American and Caribbean Countries (GRULAC) to revise the 1979 WIPO Model Law for Developing Countries on Inventions. If this language is tabled, WIPO’s normative committee on patents will continue discussions on the GRULAC proposal.
On 30 July 2015 at 8:30 PM Geneva time, the Chair (Bucura Ionescu, Romania) of WIPO’s 22nd Standing Committee on the Law of Patents (SCP) distributed the following non-paper as a pathway for future work addressing 1) Exceptions and Limitations to Patent Rights, 2) Quality of Patents, Including Opposition Systems, 3) Patents and Health, 4) Confidentiality of Communications between clients and their patent advisors and 5) Transfer of technology. The SCP is WIPO”s main normative committee dealing with patents.
28 July 2015
WIPO Standing Committee on the Law of Patents (SCP)
Written Statement of Knowledge Ecology International on Patents and Health
As the Trans-Pacific Partnership (TPP) is currently reported to be in the final stages of negotiation, it is both appropriate and urgent that this Committee is addressing the topic of patents and health.
